Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Schol PJ"'
Autor:
Tabasum S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Thapa D; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Giobbie-Hurder A; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Weirather JL; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Campisi M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Schol PJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands., Li X; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Li J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Yoon CH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 Nov 01; Vol. 11 (11), pp. 1493-1507.
Autor:
Melsen JE; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., van Ostaijen-Ten Dam MM; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., Schoorl DJA; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., Schol PJ; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., van den Homberg DAL; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., Lankester AC; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., Lugthart G; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., Schilham MW; Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Nov 24; Vol. 13, pp. 1044398. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2022).
Autor:
Knelson EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ivanova EV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tarannum M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Campisi M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lizotte PH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Ozgenc I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Noureddine M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Meisenheimer B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Chen M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Piel B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Spicer N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Obua B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Messier CM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Shannon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Graduate Medical Sciences Program, Boston University School of Medicine, Boston, Massachusetts., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Tani T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schol PJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lee-Hassett AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Zlota A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Vo HV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ha M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bertram AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Han S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gustafson CE; Deparment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Venugopal K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Haggerty TJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Albertson TP; Deparment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Hartley AV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Eser PO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li ZH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cañadas I; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Vivero M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., De Rienzo A; Deparment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Richards WG; Deparment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Abu-Yousif AO; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Appleman VA; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Gregory RC; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Parent A; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Lineberry N; Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts., Smith EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Miret JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bueno R; Deparment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2022 Aug 03; Vol. 10 (8), pp. 947-961.